Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma.
Bertagna F, Motta F, Bertoli M, Bosio G, Fisogni S, Tardanico R, Ferrari V, Antonelli A, Simeone C, Cosciani Cunico S, Giubbini R. Bertagna F, et al. Among authors: fisogni s. Nucl Med Rev Cent East Eur. 2013;16(1):3-8. doi: 10.5603/NMR.2013.0002. Nucl Med Rev Cent East Eur. 2013. PMID: 23677757 Free article.
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F. Cigognetti M, et al. Among authors: fisogni s. Mod Pathol. 2015 Aug;28(8):1043-57. doi: 10.1038/modpathol.2015.65. Epub 2015 May 29. Mod Pathol. 2015. PMID: 26022455 Free article.
In vitro antitumor activity of progesterone in human adrenocortical carcinoma.
Fragni M, Fiorentini C, Rossini E, Fisogni S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM, Claps M, Cosentini D, Salvi V, Bosisio D, Terzolo M, Missale C, Facchetti F, Memo M, Berruti A, Sigala S. Fragni M, et al. Among authors: fisogni s. Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26. Endocrine. 2019. PMID: 30367443 Free article.
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis.
Bergamini M, Dalla Volta A, Valcamonico F, Caramella I, Buffoni M, Munari E, Fisogni S, Zanotelli T, Suardi NR, Berruti A. Bergamini M, et al. Among authors: fisogni s. Case Rep Oncol. 2024 Jan 5;17(1):56-68. doi: 10.1159/000535460. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 38188482 Free PMC article.
60 results